Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as flavopiridol, cytarabine, and mitoxantrone, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Giving a new schedule of more than one drug (combination chemotherapy)
may kill more cancer cells. This phase I trial is studying the side effects, best dose, and
best schedule for flavopiridol when given together with cytarabine and mitoxantrone in
treating patients with relapsed or refractory acute leukemia.